Injectafer and Neurontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Injectafer (ferric carboxymaltose) and Neurontin (gabapentin). Common drug interactions include hypoaesthesia among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Injectafer and Neurontin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Injectafer?

Injectafer has active ingredients of ferric carboxymaltose. eHealthMe is studying from 3,270 Injectafer users. Check the latest studies of Injectafer.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.

On Jul, 05, 2026

19 people who take Injectafer and Neurontin together, and have interactions are studied.

Injectafer and Neurontin drug interactions.

What are the common drug interactions of Injectafer and Neurontin, by gender? *:

female:

Hypoaesthesia (reduced sense of touch or sensation)
Arthralgia (joint pain)
Muscle spasms (muscle contraction)
Oedema (fluid collection in tissue)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Back pain
Myalgia (muscle pain)
Heart rate irregular
Sleep disorder

male:

Arthralgia (joint pain)
Chest pain
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Injectafer and Neurontin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Back pain
Bone pain
Burning sensation
Depression
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Muscle spasms (muscle contraction)

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Dizziness
Emotional distress
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Neck pain
Oedema (fluid collection in tissue)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

Abdominal distension
Abdominal pain
Chills (felling of cold)
Dyspnoea (difficult or laboured respiration)
Influenza
Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
Nausea (feeling of having an urge to vomit)
Painful respiration
Vomiting

60+:

Fall
Abdominal pain upper
Blood urea increased
Blood urine present
Chest pain
Colitis (inflammation of colon)
Confusional state
Dehydration (dryness resulting from the removal of water)
Disease progression
Drug screen positive

What are the existing conditions these people have? *

Iron Deficiency Anaemia: 6 people, 31.58%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 21.05%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 21.05%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
Migraine (headache): 2 people, 10.53%
Vitamin D Decreased: 1 person, 5.26%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 5.26%
Anaemia Vitamin B12 Deficiency: 1 person, 5.26%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.26%
Autonomic Nervous System Imbalance (autonomic nervous system is of net equal emphasis): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Injectafer and Neurontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously